A clinical trial of the effects of estrogen in acutely psychotic women

Schizophrenia Research

Volumn 20, Issue 3, 1996, Pages 247-252

  Kulkarni, Jayashri ^a   De Castella, Anthony ^a   Smith, Deidre ^a   Taffe, John ^a   Keks, Nicholas ^a   Copolov, David ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Estrogen; Gender; Hormones; Menstrual; Schizophrenia

Indexed keywords

BENZODIAZEPINE; CHLORPROMAZINE; ESTRADIOL; ESTROGEN; HALOPERIDOL; NEUROLEPTIC AGENT; THIORIDAZINE; TRIFLUOPERAZINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; PRIORITY JOURNAL; SCHIZOPHRENIA;

EID: 0030570530     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/0920-9964(96)82949-5     Document Type: Article

References (18)

1. Angemeyer MC, Kuhn L (1988) Gender differences in age at onset of schizophrenia, an overview. Eur Arch Psychiatry Neurol Sci 237, 351-364.
2. Bedard P, Boucher R, Daigle MM, DiPaolo T (1984) Similar effect of estradiol and haloperidol on experimental tardive dyskinesia in monkeys. Psychoneuroendocrinology 9, 375-379.
3. Dennerstein L, Judd F, Davies B (1983) Psychosis and the menstrual cycle. Med J Aust 1, 524-526.
4. Di Paolo T, Payet P, Labrie F (1981) Effect of chronic estradiol and haloperidol treatment on striatal dopamine receptors. Eur J Pharmacol 73, 105-106.
5. Dupond A, DiPaolo T, Gagne B, Baarden N (1981) Effects of chronic estrogen treatment on dopamine concentrations and turnover in discrete brain nuclei of ovariectomized rats. Neurosci Lett 22, 69-74.
6. Endo M, Daiguji M, Asano Y, Yamashita L, Takahashi S (1978) Periodic psychosis recurring in association with menstrual cycle. J Clin Psychiatry 39, 456-466.
7. Foreman MM and Porter JC (1980) Effects of catechol estrogens and catecholamines on hypothalmic and corpus striatal tyrosine hydroxylase activity. J Neurochem 34, 1175-1183.
8. Goldstein JM (1988) Gender differences in the course of schizophrenia. Am J Psychiatry 145, 684-689.
9. Gordon JH, Diamond BI (1981) Antagonism of dopamine supersensitivity by estrogen. Neurochemical studies in an animal model of tardive dyskinesia. Biol Psychiatry 16, 365-371.
10. Gordon JH, Borison RL, Diamond BI (1980) Modulation of dopamine receptor sensitivity by estrogen. Biol Psychiatry 15, 389-396.
11. Hruska RE, Silbergeld EK (1980) Estrogen treatment enhances dopamine receptor sensitivity in the rat striatum. Eur J Pharmacol 61, 397-400.
12. Klaiber EL, Broverman DM, Vogel W, Kobayashi Y. (1979) Estrogen therapy for severe persistent depressions in women. Arch Gen Psychiatry 36, 550-554.
13. Koller WC, Weiner WJ, Klawans HL, Nausieda PA (1980) Influence of female sex hormones on neuroleptic-induced behavioural supersensitivity. Neuropharmacology 19, 387-391.
14. Rlecher-Rossler A, Hafner H, Stumbaum M, Maurer K, Schmidt R (1994) Can estradiol modulate schizophrenic symptomatology? Schizophr Bull 20, 203-214.
15. Sartorius N, Jablensky A, Shapiro R (1978) Cross-cultural differences in the short-term prognosis of schizophrenia psychoses. Schizophr Bull 4, 102-113.
16. Seeman MV (1983) Interaction of sex, age and neuroleptic dose. Comp Psychiatry 24, 125-128.
17. Seeman MV, Lang M (1990) The role of estrogens in schizophrenia gender differences. Schizophr Bull 16, 185-195.
18. Sumner B, Fink G (1995) Estrogen Increases the density of 5-HT2A receptors in cerebral cortex and nucleus accumbens in the female rat. J. Steroid Biochem Mol Biol (in press).